EU approves Celgene’s Vidaza to treat elderly patients with acute myeloid leukaemia
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation announced that the European Commission (EC) has approved Vidaza (azacitidine for injection)... Read More